These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 12134639

  • 1. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y.
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [Abstract] [Full Text] [Related]

  • 2. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E, Crews L, Masliah E.
    Adv Drug Deliv Rev; 2007 Sep 30; 59(11):1093-102. PubMed ID: 17869376
    [Abstract] [Full Text] [Related]

  • 3. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M, Nilsson L, Basun H, Aquilonius SM, Lannfelt L.
    Lakartidningen; 2007 Sep 30; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.
    J Neurol Sci; 2005 Jun 15; 233(1-2):145-62. PubMed ID: 15896810
    [Abstract] [Full Text] [Related]

  • 5. [Animal models of neurodegenerative diseases].
    Langui D, Lachapelle F, Duyckaerts C.
    Med Sci (Paris); 2007 Feb 15; 23(2):180-6. PubMed ID: 17291428
    [Abstract] [Full Text] [Related]

  • 6. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L, Hamdane M, Delobel P, Sambo AV, Bégard S, Ghestem A, Sergeant N, Delacourte A.
    J Soc Biol; 2002 Feb 15; 196(1):103-8. PubMed ID: 12134624
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA, Love S.
    J Neuropathol Exp Neurol; 2007 Nov 15; 66(11):1019-26. PubMed ID: 17984683
    [Abstract] [Full Text] [Related]

  • 8. What transgenic mice tell us about neurodegenerative disease.
    Gurney ME.
    Bioessays; 2000 Mar 15; 22(3):297-304. PubMed ID: 10684590
    [Abstract] [Full Text] [Related]

  • 9. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM.
    Neuropathol Appl Neurobiol; 2004 Jun 15; 30(3):215-24. PubMed ID: 15175075
    [Abstract] [Full Text] [Related]

  • 10. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V, Pan TH, LE WD.
    Cell Res; 2004 Oct 15; 14(5):347-58. PubMed ID: 15538967
    [Abstract] [Full Text] [Related]

  • 11. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration.
    Hardy J.
    Biochem Soc Trans; 2005 Aug 15; 33(Pt 4):578-81. PubMed ID: 16042548
    [Abstract] [Full Text] [Related]

  • 12. Genes and the environment in neurodegeneration.
    Coppedè F, Mancuso M, Siciliano G, Migliore L, Murri L.
    Biosci Rep; 2006 Oct 15; 26(5):341-67. PubMed ID: 17029001
    [Abstract] [Full Text] [Related]

  • 13. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G, Schlüter OM, Südhof TC.
    Nat Neurosci; 2008 Mar 15; 11(3):301-8. PubMed ID: 18297066
    [Abstract] [Full Text] [Related]

  • 14. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD, Bitan G, Teplow DB.
    J Neurosci Res; 2002 Sep 01; 69(5):567-77. PubMed ID: 12210822
    [Abstract] [Full Text] [Related]

  • 15. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC.
    Ann N Y Acad Sci; 2005 Dec 01; 1066():181-221. PubMed ID: 16533927
    [Abstract] [Full Text] [Related]

  • 16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J, Levy M, Dickson DW, Potter H.
    Brain; 2006 Nov 01; 129(Pt 11):3020-34. PubMed ID: 16987932
    [Abstract] [Full Text] [Related]

  • 17. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R, Cruts M, van Broeckhoven C.
    Hum Mutat; 2004 Oct 01; 24(4):277-95. PubMed ID: 15365985
    [Abstract] [Full Text] [Related]

  • 18. Tau gene mutations and their effects.
    Goedert M.
    Mov Disord; 2005 Aug 01; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [Abstract] [Full Text] [Related]

  • 19. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
    Armstrong RA, Lantos PL, Cairns NJ.
    Neuropathology; 2008 Aug 01; 28(4):351-65. PubMed ID: 18433435
    [Abstract] [Full Text] [Related]

  • 20. Neuropathological spectrum of synucleinopathies.
    Jellinger KA.
    Mov Disord; 2003 Sep 01; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.